Footwear Difference in Sports Use in Runners With Functional Equinus

Last updated: April 15, 2025
Sponsor: Universidad Católica de Ávila
Overall Status: Active - Recruiting

Phase

N/A

Condition

Athletic Injuries

Treatment

250 mg Nimbus shoe

Clinical Study ID

NCT06930287
13/12/2024
  • Ages 18-50
  • All Genders

Study Summary

Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. This is a Novablast shoe with a mixed profile for training and competition with 8mm drp and higher midfoot compression range with less lateral containment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with functional equine

  • regular runners

Exclusion

Exclusion Criteria:

  • patients with severe heterometry (more than 1 cm).

  • Recent lower limb interventions

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: 250 mg Nimbus shoe
Phase:
Study Start date:
March 31, 2025
Estimated Completion Date:
December 30, 2025

Connect with a study center

  • Universidad Pontificia de Salamanca

    Salamanca,
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.